Analysis of L-myc and GSTM1 genotypes in Chinese non-small cell lung carcinoma patients

Lung Cancer

Volumn 15, Issue 3, 1996, Pages 355-366

  Ge, Hong ^a   Lam, Wah Kit ^b   Lee, Joseph ^c   Wong, Maria Pik ^b   Yew, Wing Wei ^c   Lung, Maria Li ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c GRANTHAM HOSPITAL   (Hong Kong)

Author keywords

genotype; GST; L myc; lung cancer

Indexed keywords

GLUTATHIONE TRANSFERASE;

ARTICLE; CONTROLLED STUDY; ETHNIC GROUP; GENOTYPE; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; ONCOGENE MYC; PRIORITY JOURNAL;

EID: 0030297801     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-5002(95)00598-6     Document Type: Article

References (37)

1. [1] Ayesh R, Idle JR, Ritchie JC, Crother MJ, Hetzel MR. Metabolic oxidation phenotypes as markers for susceptibility to lung cancer. Nature 1984; 312: 169-170.
2. [2] Caporaso NE, Tucker MA, Hoover R, Hayes RB, Pickle LW, Issaq H, Muschik G, Green-Gallo L, Buivys D, Aisner S, Resau J, Trump BF, Tollerud D, Weston A, Harris CC. Lung cancer and the debrisoquine metabolic phenotype. J Natl Cancer Inst 1990; 85: 1264-1272.
3. [3] Harris CC, Mulvihill JJ, Thorgirsson SS, Minna JD. Individual differences in cancer susceptibility [clinical conference]. Ann Intern Med 1980; 92: 809-825.
4. [4] Weinberg RA. Oncogenes, antioncogenes and the molecular basis of multistep carcinogenesis. Cancer Res 1989; 49: 3713-3721.
5. [5] Nau MM, Brooks BJ, Jr Battey JF, Sausville E, Gazdar AF, Kirsch IR, McBride OW, Bertness V, Hollis GF, Minna JD. L-myc, a new myc related gene amplified and expressed in human small cell lung cancer. Nature 1985; 318: 69-73.
6. [6] Kawashima K, Shikama H, Imoto K, Izawa M, Naruke T, Okabayashi K, Nishimura S. Close correlation between restriction fragment length polymorphism of the L-myc gene and metastasis of human lung cancer to the lymph nodes and other organs. Proc Natl Acad Sci USA 1988; 85: 2353-2356.
7. [7] Kawashima K, Nomura S, Hirai H, Fukushi S, Karube T, Takeuchi K, Naruke T, Nishimura S. Correlation of L-myc RFLP with metastasis, prognosis and multiple cancer in lung-cancer patients. Int J Cancer 1992; 50: 557-561.
8. [8] Kakehi Y, Yoshida O. Restriction fragment length polymorphism of the L-myc gene and susceptibility to metastasis in renal cancer patients. Int J Cancer 1989; 43: 391-394.
9. [9] Saranath D, Panchal RG, Nair R, Mehta AR, Sanghavi V, Deo MG. Restriction-fragment-length polymorphism of the L-myc gene in oral-cancer patients. Br J Cancer 1990; 61: 530-533.
10. [10] Ishizaki K, Kato M, Ikenaga M, Honda K, Ozawa K, Toguchida J. Correlation of L-myc genotypes to metastasis of gastric cancer and breast cancer. J Natl Cancer Inst 1990; 82: 238-239.
11. [11] Champeme M-H, Bieche I, Latil A, Hacene K, Lidereau R. Association between restriction fragment length polymorphism of the L-myc gene and lung metastasis in human breast cancers. Int J Cancer 1992; 50: 6-9.
12. [12] Young J, Buttenshaw R, Butterworth L, Ward M, Searle J, Leggett B, Chenevix-Trench G. Association of the SS genotype of the L-myc gene and loss of 18q sequences with a worse clinical prognosis in colorectal cancers. Oncogene 1994; 9: 1053-1106.
13. [13] Tamai S, Sugimura H, Caporaso NE, Resau JH, Trump BF, Weston A, Harris CC. Restriction fragment length polymorphism analysis of the L-myc gene locus in a case-control study of lung cancer. Int J Cancer 1990; 46: 411-415.
14. [14] Tefre T, Borresen AL, Aamdal S, Brogger A. Studies of the L-myc DNA polymorphism and relation to metastasis in Norwegian lung cancer patients. Br J Cancer 1990; 61: 809-812.
15. [15] Weston A, Caporaso NE, Perrin LS, Sugimura H, Tamai S, Krontirts TG, Trump BF, Hoover RN, Harris CC. Relationship of H-ras-1, L-myc, and p53 polymorphisms with lung cancer risk and prognosis. Environ Health Perspec 1992; 98: 61-67.
16. [16] Ikeda I, Ishizaka Y, Ochiai M, Sakai R, Itabashi M, Onda M, Sugimura T, Nagao M. No correlation between L-myc restriction fragment length polymorphism and malignancy of human colorectal cancers. Jpn J Cancer Res 1988; 79: 674-676.
17. [17] Chenevix-Trench G, Southall M, Kidson C. Restriction fragment, length polymorphisms of L-myc and myb in human leukaemia and tymphoma in relation to age-selected controls. Br J Cancer 1989; 60: 872-874.
18. [18] Taylor JA, Bell DA, Nagorney D. L-myc proto-oncogene alleles and susceptibility to hepatocellular carcinoma. Int J Cancer 1993; 54: 927-930.
19. [19] Board P, Coggan M, Johnstop P, Ross V, Suzuki T, Webb G. Genetic heterogeneity of the human glutathione transferases: a complex of gene families. Pharmacol Ther 1990; 48: 357-369.
20. [20] Hayashi S-I, Watanabe J, Kawajiri K. High susceptibility to lung cancer analyzed in terms of combined genotypes of P4501A1 and Mu-class glutathione S-transferase genes. Jpn J Cancer Res 1992; 83: 866-870.
21. [21] Nazar-Stewart V, Motulsky AG, Eaton DL, White E, Hornung SK, Leng Z T, Stapleton P, Weiss NS. The glutathione S-transferase μ polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res 1993; 53: 2313-2318.
22. [22] London SJ, Daly AK, Cooper J, Navidi WC, Carpenter CL, Idle JR. Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California. J Natl Cancer Inst 1995; 87: 1246-1253.
23. [23] Baranov VS, Ivaschenko T, Bakay B, Aseev M, Belotserkovskaya R, Baranova H, Malet P, Perriot J, Mouraire P, Baskakov VN, Savitskyi GA, Gorbushin S, Deyneka SI, Michnin E, Barchuck A, Vakharlovsky V, Pavlov G, Shilko VI, Guembitzkaya T, Kovaleva L. Proportion of the GSTM1 O/O genotype in some Slavic populations and its correlation with cystic fibrosis and some multifactorial diseases. Hum Genet 1996; 97: 516-520.
24. [24] Brockmoller J, Kerb R, Drakoulis N, Nitz M, Roots I. Genotype and phenotype of glutathione S-transferase class μ isoenzymes μ and ψ in lung cancer patients and controls. Cancer Res 1993; 53: 1004-1011.
25. [25] Zhong S, Howie AH, Kettere B, Taylor J, Hayes JD, Beckett GJ, Wathen CG, Wolf CR, Spurt NK. Glutathione S-transerase μ locus: use of genootyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis 1991; 12: 1533-1537.
26. [26] Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Venna JE, Brasure JR, Laughlin R, Nemoto Y, Michalek AM, Harrington A, Ford TD, Shields PG. Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res 1995; 55: 3483-3485.
27. [27] Toussaint C, Albin N, Massaad L, Grunenwald D, Parise O, Jr Morizet J, Gouyette A, Chabot GG. Main drug-and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues. Cancer Res 1993; 53: 4608-4612.
28. [28] Seidegard J, Pero RW, Markowitz MM, Rousch G, Miller DG, Beattie EJ. Isoenzyme(s) of glutathione transferase (class μ) as a marker for the susceptibility to lung cancer: a follow-up study. Carcinogenesis 1990; 11: 33-36.
29. [29] Lin HJ, Probst-Hensch NM, Ingles S, Han C-Y, Lin BK, Lee DB. Glutathione transferase (GSTM1) null genotype, smoking, and prevalence of colorectal adenomas. Cancer Res 1995; 55: 1224-1226.
30. [30] Lam KY, Fu KH, Wong MP, Wang EP. Significant change in the distribution of histologic types of lung cancer in Hong Kong. Pathology 1993; 25: 103-105.
31. [31] Koo LC, Ho JHC. Diet as a confounder of the association between air pollution and female lung cancer: Hong Kong studies on exposures to environmental tobacco smoke, incense, and cooking fumes as examples. Lung Cancer 1996; 14(Suppl. 1): S47-S61.
32. [32] Lung ML, Wong M, Lam WK, Lau KS, Kwan S, Fu K-H, Cheung H, Yew WW. Incidence of ras oncogene activation in lung carcinomas in Hong Kong. Cancer 1992; 70: 760-763.
33. [33] Sambrook J, Fritsh EF, Maniatis T. Isolation of high-molecular-weight DNA from mammalian cells. In: Sambrook J, editor. Molecular Cloning: A Laboratory Manual. Vol. 2. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 1989; 9.16-9.22.
34. [34] Hollstein MC, Wild CP, Bleicher F, Chutimataewin S, Harris CC, Srivatanakul P, Montesano R, Srivatanakul P. p53 mutations and aflatoxin. B1 exposure in hepatocellular carcinoma patients from Thailand. Int J Cancer 1993; 53: 51-55.
35. [35] Ge H, Lam WK, Lee J, Wong MP, Fu KH, Yew WW, Lung ML. Detection and evaluation of p53 intron 2 polymorphism in lung carcinomas in Hong Kong. Int J Cancer (Pred. Oncol.) 1996; 69: 120-124.
36. [36] Mills NE, Fishman CL, Rom WN, Dubin N, Jacobson DR. Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma. Cancer Res 1995; 55: 1444-1447.
37. [37] Lung ML, Wong MP, Skaanild MT, Fok CL, Lam WK, Yew WW. p53 mutations in non-small cell lung carcinomas in Hong Kong. Chest 1996; 109: 718-726.